Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis

@inproceedings{Machado2016TreatmentPI,
  title={Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis},
  author={Marina Amaral de {\'A}vila Machado and Cristiano Soares de Moura and Felipe Ferr{\'e} and Sasha Bernatsky and Elham Rahme and Francisco de Assis Acurcio},
  booktitle={Revista de saude publica},
  year={2016}
}
OBJECTIVE To evaluate treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis who started therapies with disease-modifying antirheumatic drugs (DMARD) and tumor necrosis factor blockers (anti-TNF drugs). METHODS This retrospective cohort study from July 2008 to September 2013 evaluated therapy persistence, which is defined as the period between the start of treatment until it is discontinued, allowing for an interval of up to 30 days between the prescription end… CONTINUE READING
1 Citations
27 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide

  • LMH Mota, BA Cruz, CV Brenol, IA Pereira, LS Rezende-Fronza, MB Bertolo
  • Rev Bras Reumatol
  • 2012

Similar Papers

Loading similar papers…